Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Promyelocytic, Acute

Clinical trial condition

Leukemia, Promyelocytic, Acute

Explore clinical trials studying Leukemia, Promyelocytic, Acute. Study availability and eligibility vary by location and protocol.

87 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Promyelocytic, Acute trial results

Completed

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00357305

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +78 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia

NCT00008697

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

NCT00520208

Conditions: Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Northwestern University Chicago, Illinois, United States

UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

NCT00114257

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +46 more
Locations: M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Completed

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome

NCT00005064

Conditions: Adult Acute Promyelocytic Leukemia (M3), Anemia, Anemia, Refractory, +34 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia

NCT00006213

Conditions: Adult Acute Promyelocytic Leukemia (M3), Anemia, Anemia, Refractory, +37 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

NCT00016159

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

NCT00098826

Conditions: Acute Undifferentiated Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +60 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Completed

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

NCT00002547

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details